- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Fake versions of Covishield identified by WHO in India
The WHO warned that fake vaccines " pose a serious risk to global public health".
New Delhi: The World Health Organisation (WHO) said it has identified counterfeit versions of India's primary Covid vaccine, Covishield, BBC reported.
The doses were seized by authorities in India and Africa between July and August, a WHO statement said.
It also said the vaccine's maker, the Serum Institute of India, confirmed that the doses were fake.
The WHO warned that fake vaccines "pose a serious risk to global public health".
It called for their removal from circulation.
Covishield is the Indian-made version of AstraZeneca's jab and is the most widely used vaccine in India with more than 486 million doses administered so far.
Serum had supplied millions of Covishield vaccines to countries in Asia, Africa and South America - as part of deals that were inked with various governments and the global Covax scheme for poorer countries.
Read also: Study on mixing of Covaxin, Covishield doses get DCGI okay
India, which is the second worst-affected country in the world, aims to vaccinate all its people by the end of this year.
About 13 per cent of the population has been fully vaccinated since the beginning of the drive in January.
Read also: Covishield booster dose desirable: Serum Institute Chairman
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.